Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study
OPEN BMC medicine | 14 Jul 2017
A Perez-Cornago, PN Appleby, T Pischon, KK Tsilidis, A Tjønneland, A Olsen, K Overvad, R Kaaks, T Kühn, H Boeing, A Steffen, A Trichopoulou, P Lagiou, M Kritikou, V Krogh, D Palli, C Sacerdote, R Tumino, HB Bueno-de-Mesquita, A Agudo, N Larrañaga, E Molina-Portillo, A Barricarte, MD Chirlaque, JR Quirós, P Stattin, C Häggström, N Wareham, KT Khaw, JA Schmidt, M Gunter, H Freisling, D Aune, H Ward, E Riboli, TJ Key and RC Travis
The relationship between body size and prostate cancer risk, and in particular risk by tumour characteristics, is not clear because most studies have not differentiated between high-grade or advanced stage tumours, but rather have assessed risk with a combined category of aggressive disease. We investigated the association of height and adiposity with incidence of and death from prostate cancer in 141,896 men in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
* Data courtesy of Altmetric.com